Key facts
- This page summarizes James L. Cox's Form 4 filing for Adagio Medical Holdings, Inc. (ADGM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Aug 2024, 08:00.
James L. Cox - 31 Jul 2024 Form 4 Insider Report for Adagio Medical Holdings, Inc. (ADGM)
- Reporting relationship
- Director
- Issuer ticker
- ADGM
- Reported as of
- 31 Jul 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Aug 2024, 08:00:11 UTC
- Prior SEC filing
- 23 Feb 2024
- Next SEC filing
- 21 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Dahldorf, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
James L. Cox filed Form 4 for Adagio Medical Holdings, Inc. (ADGM) on 02 Aug 2024.
Change
- Previous filing in this sequence was filed on 23 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADGM
transaction
Common Stock
Other
- Transaction value
- Shares
- +36,698
- Change %
- Price
- Shares after
- 36,698
- Date
- 31 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Pursuant to the business combination (the "Business Combination") contemplated by the Business Combination Agreement (the "BCA"), dated February 13, 2024, as amended, by and among Adagio Medical Holdings, Inc. (formerly known as Aja Holdco Inc., "New Adagio" and following the completion of the Business Combination, the "Issuer"), ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc. ("Adagio") and certain other parties thereto, as described in the Registration Statement on Form S-4 (File No. 333-278811) filed with the U.S. Securities and Exchange Commission and declared effective on July 12, 2024, acquired by the reporting person in exchange for the shares of Adagio common stock held by the reporting person prior to the completion of the Business Combination.